Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry

Histopathology

Volumn 54, Issue 5, 2009, Pages 529-538

  Wong, Newton A C S ^a   Melegh, Zsombor ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antigen retrieval; CD117; Immunohistochemistry; Primary antibody; Sensitivity; Specificity

Indexed keywords

ANTIBODY; C19 POLYCLONAL ANTIBODY; RB 1518 POLYCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR; T595 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANGIOSARCOMA; ANTIGEN RETRIEVAL; ARTICLE; CARCINOID; CHONDROSARCOMA; DERMATOFIBROSARCOMA PROTUBERANS; DESMOID TUMOR; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; GANGLIONEUROMA; GASTROINTESTINAL STROMAL TUMOR; GLOMUS TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPOSI SARCOMA; LEIOMYOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MELANOMA; NEURILEMOMA; NEUROFIBROMA; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ABDOMINAL NEOPLASMS; ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; MESODERM; PROTO-ONCOGENE PROTEINS C-KIT; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 64549158437     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03272.x     Document Type: Article

References (33)

1. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissue: value in the diagnosis of mast cell disorders. Hum. Pathol. 1998 29 498 504.
2. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am. J. Clin. Pathol. 2002 117 188 193.
3. Fletcher CD, Berman JJ, Corless C et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum. Pathol. 2002 33 459 465.
4. van Oosterom AT, Judson I, Verweij J et al. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001 358 1421 1423.
5. Prenen H, Cools J, Mentens N et al. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate. Clin. Cancer Res. 2006 12 2622 2627.
6. NHS National Institute for Clinical Excellence. Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours. Technology Appraisal 86, October 2004. Available at: http://www.nice.org.uk/ TA086guidance. Last accessed 2 June 2008.
7. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008 53 245 266.
8. Hodi FS, Friedlander P, Corless CL et al. Major response to imatinib mesylate in KIT-mutated melanoma. J. Clin. Oncol. 2008 26 2046 2051.
9. Blay JY, Bonvalot S, Casali P et al. GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann. Oncol. 2005 16 566 578.
10. Miettinen M. Are desmoid tumors KIT positive? Am. J. Surg. Pathol. 2001 25 549 550.
11. Ahmed A, Gilbert-Barness E, Lacson A. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols. Pediatr. Dev. Pathol. 2004 7 342 347.
12. Lucas DR, al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW, Mott MJ. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am. J. Clin. Pathol. 2003 119 339 345.
13. Parfitt JR, Rodriguez-Justo M, Feakins R, Novelli MR. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour. Histopathology 2008 52 816 823.
14. Tamborini E, Bonadiman L, Greco A et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin. Cancer Res. 2004 10 938 943.
15. Ibrahim M. The Alimentary Tract (Pilot) Module. Immunocytochemistry 2007 5 191 194.
16. Assessment Run 21 2007 [Nordic Immunohistochemistry Quality Control Web site]. 30 November 2007. Available at: http://www.nordiqc.org/Run-21-B4/ Assessment/assessment-CD117.htm. Last accessed 8 January 2008.
17. Subramanian S, West RB, Marinelli RJ et al. The gene expression profile of extraskeletal myxoid chondrosarcoma. J. Pathol. 2005 206 433 444.
18. Bozzi F, Tamborini E, Negri T et al. Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors. Cancer 2007 109 1638 1645.
19. McIntyre A, Summersgill B, Grygalewicz B et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res. 2005 65 8085 8089.
20. Papadimitriou CA, Topp MS, Serve H et al. Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. Eur. J. Cancer 1995 31A 2371 2378.
21. Moses AV, Jarvis MA, Raggo C et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J. Virol. 2002 76 8383 8399.
22. Tamborini E, Bonadiman L, Negri T et al. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer. Clin. Cancer Res. 2004 10 8214 8219.
23. Bateman AC, Judd M, Radenkovic D, Johnson CD. CD117/KIT expression in pancreatic adenocarcinoma. Pancreas 2008 36 76 79.
24. Yamashita S. Heat-induced antigen retrieval: mechanisms and application to histochemistry. Prog. Histochem. Cytochem. 2007 41 141 200.
25. Espinosa I, Lee CH, Kim MK et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am. J. Surg. Pathol. 2008 32 210 218.
26. Miettinen M, Lasota J. KIT expression in angiosarcomas and in fetal endothelial cells. Lack of c-kit mutations in exons 11 and 17 in angiosarcoma. Mod. Pathol. 2000 13 536 541.
27. Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod. Pathol. 2003 16 229 235.
28. Geller MA, Argenta P, Bradley W et al. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol. Oncol. 2004 95 632 636.
29. Smithey BE, Pappo AS, Hill DA. C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am. J. Surg. Pathol. 2002 26 486 492.
30. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am. J. Surg. Pathol. 2002 26 493 497.
31. Martland GT, Goodman AJ, Shepherd NA. CD117 expression in oesophageal carcinosarcoma: a potential diagnostic pitfall. Histopathology 2004 44 77 80.
32. Sampietro G, Tomasic G, Collini P et al. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl. Immunohistochem. Mol. Morphol. 2000 8 49 56.
33. Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA. c-Kit is not expressed in malignant mesothelioma. Mod. Pathol. 2003 16 818 822.